HEALIUS LIMITED

0.00%

63.5¢

Market Cap $461.0M

Healthcare Diagnostics & Research

Healius Limited is a healthcare company. The Company’s specialized pathology businesses... Healius Limited is a healthcare company. The Company’s specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers its medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include QML, Laverty, Dorevitch, Western Diagnostic Pathology, TML, Agilex Biolabs, and Abbott Pathology, among others. These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia. It provides specialty diagnostic services to consumers and their referring practitioners.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

HLS

Ann: Change in substantial holding from MUFG

19:19

Last post

ASX News

HLS

Ann: Change of Director's Interest Notice - Kathy Ostin

15:48

287

15:48

Last post CEOD

287

HLS

Ann: Change in substantial holding

10:38

456

10:38

Last post gaxford

456

HLS

Ann: Half Year 2026 Results Presentation

28/02/26

10K

28/02/26

Last post Aqua65

10K

HLS

Ann: Change in substantial holding

23/02/26

257

23/02/26

Last post

ASX News

257

HLS

Ann: Healius announces 1H 2026 results

18/02/26

281

18/02/26

Last post

ASX News

281

HLS

Ann: Half Yearly Report and Accounts

18/02/26

213

18/02/26

Last post

ASX News

213

HLS

Ann: Becoming a substantial holder

17/02/26

4.6K

17/02/26

Last post flyingscot

4.6K

See All Discussions

Timeline

Change in substantial holding from MUFG
05 Mar 18:59	Share

Change of Director's Interest Notice - Kathy Ostin
05 Mar 12:49	Share

Change in substantial holding
04 Mar 18:31	Share

Change in substantial holding
23 Feb 16:27	Share

Healius announces 1H 2026 results
18 Feb 08:16	Share

Half Year 2026 Results Presentation
18 Feb 08:16	Share

Half Yearly Report and Accounts
18 Feb 08:16	Share

Change in substantial holding from MUFG
09 Feb 18:54	Share

Change in substantial holding
06 Feb 18:02	Share

Becoming a substantial holder
05 Feb 17:41	Share

Initial Director's Interest Notice - Bruce Robinson
02 Feb 10:34	Share

Webcast details for Healius 1H26 Results
27 Jan 11:32	Share

Ceasing to be a substantial holder
24 Dec 08:33	Share

Change in substantial holding from MUFG
16 Dec 18:32	Share

Change in substantial holding
15 Dec 19:14	Share

Board Changes
08 Dec 09:09	Share

Change in substantial holding
04 Dec 14:36	Share

Change in substantial holding from CBA
03 Dec 11:47	Share

Change in substantial holding
02 Dec 14:25	Share

Healius wins contract for supply of services to ADF
01 Dec 13:32	Share

Initial Director's Interest Notice - Steven Rubic
01 Dec 08:32	Share

Change of Director's Interest Notice - Paul Anderson
19 Nov 12:24	Share

Change of Director's Interest Notice - Kathy Ostin
10 Nov 17:34	Share

Notification regarding unquoted securities - HLS
10 Nov 17:29	Share

Becoming a substantial holder
04 Nov 16:42	Share

Change in substantial holding
03 Nov 16:26	Share

Appendix 3Y - Paul Anderson
03 Nov 13:09	Share

Amended Constitution
30 Oct 13:54	Share

2025 AGM - Results of Meeting
30 Oct 13:45	Share

2025 AGM - Chair & CEO Addresses
30 Oct 10:17	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 63.5¢		Change 0.000(0.00%)		Mkt cap ! $461.0M

Open	High	Low	Volume
64.0¢	65.5¢	63.0¢	3.444M

Buyers (Bids)

Vol.	Price($)
9190	63.0¢

Sellers (Offers)

Price($)	Vol.
65.0¢	40028

Last trade - 16.25pm 05/03/2026 (20 minute delay)

HLS (ASX) Chart

HEALIUS LIMITED

Corporate Spotlight
Not Yet Available

Latest Threads

Advance Metals Delivers Broad Silver-Gold Hits at Yoquivo, Pointing to Near-Term Major Resource Upgrade

Timeline

Featured News

Latest Articles

Healius selling Lumus to slash debt & return cash to investors

Healius is selling Lumus Imaging in a $965 million deal to pay down debt and 'return cash to shareholders'.

Healius (ASX:HLS) dealt blow as Takeovers Panel sees no issue with ACL’s (ASX:ACL) off-market bid

Healius (ASX:HLS) has been dealt a blow as the Takeovers Panel announced its decision against conducting proceedings over Australian Clinical Labs' (ACL) takeover bid last month.

Healius (ASX:HLS) reaffirms “no-action” stance regarding takeover proposal from ACL (ASX:ACL)

Last week, Australian Clinical Labs (ASX:ACL) made an off-market takeover bid to acquire Healius (ASX:HLS), but on Monday, Healius reaffirmed its direction to shareholders to take "no action" in relation to the offer.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

HEALIUS LIMITED

Corporate SpotlightNot Yet Available

Latest Threads

Advance Metals Delivers Broad Silver-Gold Hits at Yoquivo, Pointing to Near-Term Major Resource Upgrade

Timeline

Featured News

Latest Articles

Healius selling Lumus to slash debt & return cash to investors

Healius is selling Lumus Imaging in a $965 million deal to pay down debt and 'return cash to shareholders'.

Healius (ASX:HLS) dealt blow as Takeovers Panel sees no issue with ACL’s (ASX:ACL) off-market bid

Healius (ASX:HLS) has been dealt a blow as the Takeovers Panel announced its decision against conducting proceedings over Australian Clinical Labs' (ACL) takeover bid last month.

Healius (ASX:HLS) reaffirms “no-action” stance regarding takeover proposal from ACL (ASX:ACL)

Last week, Australian Clinical Labs (ASX:ACL) made an off-market takeover bid to acquire Healius (ASX:HLS), but on Monday, Healius reaffirmed its direction to shareholders to take "no action" in relation to the offer.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available